Le Lézard
Classified in: Health, Science and technology, Business
Subject: PDT

New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine



NEW YORK, July 3, 2015 /PRNewswire/ -- Obsidian HDS, the developer of PharmaShine ( www.pharmashine.com ) - an online service for the management of data on pharmaceutical and device industry payments to healthcare professionals announced today that PharmaShine now includes the 2014 Open Payments General and Research data released by the Center for Medicare Services on June 30. The data disclosed on Open Payments for 2014 includes information on 11.4 million transactions between industry and providers totaling $6.49 billion and is the largest public disclosure of its kind to date.   With the inclusion of the new Open Payments data, PharmaShine now tracks over 19 million individually reported payment transactions.   PharmaShine provides services to major academic health science systems, including Emory, Stanford, and the University of Pennsylvania as well as leading clinical research centers such as the City of Hope National Medical Center.

George Dunston, Co-Founder and Managing Director of Obsidian HDS, said, "The most recent Open Payments update reveals the vast scale of the data set. Hospitals, clinics, research centers, medical schools and other sophisticated healthcare organizations need to assemble the proper resources to successfully utilize this data to support their compliance and procurement needs.   PharmaShine and its suite of online applications makes working with the Open Payments data quick, easy, and hassle free, saving time, human resources, and money."

About Obsidian HDS

Obsidian Healthcare Disclosure Services, LLC, formed in 2008 is a developer of online compliance and disclosure solutions for the healthcare industry. Co-Founded by a former in-house attorney at a major pharmaceutical company and a finance professional, Obsidian HDS launched its first online application, PharmaShine, in August of 2009. PharmaShine is an internet-based system for the collection, disclosure, and management of pharmaceutical and medical device industry payments to healthcare professionals. PharmaShine currently tracks over 19 million individual transactions to over 700,000 physicians, physician assistants, and nurse practitioners across the United States.   PharmaShine subscribers include top medical schools, major healthcare systems, leading research centers, and healthcare companies. For more information please visit www.pharmashine.com.

Contact:
George Dunston
gdunston@obsidianhds.com

PRLog ID: www.prlog.org/12471866

SOURCE Obsidian HDS LLC


These press releases may also interest you

at 20:15
The next frontier is truly the mind. To explore our vast galaxy, one of the most useful avenues has been Virtual Reality (VR). What makes VR so special is its ability to allow you to transport into another world without literally having to move an...

at 16:50
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150...

at 16:00
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult...

at 15:00
Evolus, Inc. today announced the presentation of data from the Phase III comparative clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American Academy of Dermatology (AAD) meeting....

at 11:00
Veterans gathered to bond and learn adaptive winter sports techniques from experienced instructors at the Arizona Snowbowl. During the two-day-adaptive ski and snowboard experience with Wounded Warrior Project® (WWP), some veterans with injuries...

at 08:00
Cardax, Inc. announced today that ZanthoSyn® (60 count), the Company's premium astaxanthin dietary supplement for inflammatory health and longevity, was the top selling product in Hawaii GNC stores for the fourth quarter of 2017, based on...




News published on 3 july 2015 at 10:42 and distributed by: